SEC Filings for Dr. Reddy's Laboratories Ltd (RDY)

$ 51.89   -0.37 (-0.71%) Volume: 225.82k 7:00 PM EDT Jul 9, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341002/07/2007
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934912/11/2006
424B3Prospectus [Rule 424(b)(3)]35911/17/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19347111/16/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934711/16/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341411/13/2006
F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuers10311/13/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19344611/13/2006
424B3Prospectus [Rule 424(b)(3)]35811/13/2006
F-6EFRegistration of American Depository Receipt shares, immediately effective411/09/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341211/09/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934810/10/2006
20-FRegistration statement / Annual report / Transition report16810/02/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19344409/11/2006
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934107/17/2006
293031323334353637383940414243